CARE Ratings (CARERATING) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
19 May, 2026Executive summary
Achieved broad-based growth in FY26, with consolidated revenue rising 18% YoY to ₹473.07 Cr and strong improvements in profitability and margins across ratings, non-ratings, and international businesses.
Indian economy grew 7.6% in FY26, supporting business momentum despite global headwinds and energy price pressures.
Board recommended a final dividend of INR 14 per share, totaling INR 22 for the year, subject to shareholder approval.
Subsidiaries turned profitable, with CareEdge Analytics and Advisory achieving breakeven and international units expanding.
Audited standalone and consolidated financial results for FY26 were approved, with unmodified audit opinions issued.
Financial highlights
Standalone revenue from operations for FY26 was ₹387.72 Cr, up 15% YoY; standalone PAT was ₹174.39 Cr, up 18% YoY; standalone operating margin was 48%.
Consolidated revenue was ₹473.07 Cr, up 18% YoY; consolidated operating profit was ₹197.39 Cr, up 27% YoY; consolidated PAT was ₹173.69 Cr, up 24% YoY; consolidated operating margin was 42%.
Ratings segment revenue was ₹423.05 Cr, up 17% YoY; non-ratings segment revenue was ₹50.01 Cr, up 19% YoY.
EPS for FY26 stood at ₹57.06 (consolidated) and ₹58.13 (standalone).
Total consolidated assets as of March 31, 2026, stood at ₹1,10,473.70 lakhs.
Outlook and guidance
FY27 GDP growth projected at 6.7%, revised down from 7.2% due to global oil prices and El Niño risks.
Demand for independent credit risk opinions expected to rise amid uncertainty.
Focus on scaling non-ratings and international businesses, leveraging technology and AI for efficiency.
Union Budget 2026-27 is expected to support sustained growth with fiscal discipline.
Management will monitor the impact of new labour codes and adjust compensation structures as needed.
Latest events from CARE Ratings
- Strong revenue and margin growth, led by ratings, with regulatory and product developments.CARERATING
Q3 25/2611 Feb 2026 - Revenue and PAT rose 19% and 16% year-over-year, led by ratings business; Board reconstituted committees.CARERATING
Q1 24/2518 Nov 2025 - Strong revenue and profit growth, global expansion, and interim dividend declared.CARERATING
Q2 24/2518 Nov 2025 - Record revenue, profit growth, and international expansion marked a strong FY25.CARERATING
Q4 24/2518 Nov 2025 - Strong profit growth, interim dividend, and strategic subsidiary stake sale in Q2 FY26.CARERATING
Q2 25/2614 Nov 2025 - Double-digit growth in income and profits, with stable governance and clean audit review.CARERATING
Q1 25/268 Aug 2025 - Q3FY25 revenue and profit surged YoY, led by ratings and non-ratings growth.CARERATING
Q3 24/255 Jun 2025